biote stock kpis
Want to see BTMD full AI Analyst Report?
Revenue by Type
biote reported revenue by type of $48.86M in Q2 2025, down 0.3% from Q1 2025 and down 0.6% year over year. The highest value was $51.38M in Q3 2024.
Distinguishes revenue streams such as product sales, services, and licensing to reveal differences in scalability, margin profile, and long-term stability of Biote’s business model.
Biote's revenue from Products shows a steady upward trend, but recent quarters reveal a slight decline, aligning with the company's flat overall revenue and challenges in procedure revenue. Meanwhile, Services revenue has surged significantly, reflecting strong growth in dietary supplements, particularly through e-commerce. The earnings call highlights strategic restructuring and cost management efforts aimed at overcoming clinic attrition and enhancing growth. Despite the challenges, Biote's focus on dietary supplements and internal efficiencies could drive future revenue stability and growth.
No longer reported by the company (last reported Q2 2025)
BTMD Revenue by Type
| Period | Products | Services | Total |
|---|---|---|---|
| Q2 2025Jun 30, 2025 | $47.66M | $1.21M | $48.86M |
| Q1 2025Mar 31, 2025 | $47.02M | $1.97M | $48.99M |
| Q4 2024Dec 31, 2024 | $48.29M | $1.55M | $49.83M |
| Q3 2024Sep 30, 2024 | $49.81M | $1.58M | $51.38M |
| Q2 2024Jun 30, 2024 | $48.11M | $1.06M | $49.17M |
| Q1 2024Mar 31, 2024 | $46.03M | $769.00K | $46.80M |
| Q4 2023Dec 31, 2023 | $44.94M | $768.00K | $45.70M |
| Q3 2023Sep 30, 2023 | $44.83M | $726.00K | $45.56M |
| Q2 2023Jun 30, 2023 | $48.65M | $605.00K | $49.26M |
| Q1 2023Mar 31, 2023 | $44.16M | $688.00K | $44.84M |
| Q4 2022Dec 31, 2022 | $44.01M | $473.00K | $44.48M |
| Q3 2022Sep 30, 2022 | $41.57M | $396.00K | $41.97M |
| Q2 2022Jun 30, 2022 | $40.79M | $570.00K | $41.36M |
| Q1 2022Mar 31, 2022 | $36.76M | $385.00K | $37.14M |
| Q4 2021Dec 31, 2021 | $36.98M | $557.00K | $37.54M |
| Q3 2021Sep 30, 2021 | $35.12M | $448.00K | $35.57M |
| Q2 2021Jun 30, 2021 | $34.31M | $443.00K | $34.75M |
| Q1 2021Mar 31, 2021 | $31.19M | $350.00K | $31.54M |

